ConductScience.org, home

Trial · NCT07894393

Haemodynamic Effects of Four Sevoflurane Wash-In Strategies After Tracheal Intubation

NCT07894393, Not applicable, Completed, Ataturk University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Haemodynamic Effects of Four Sevoflurane Wash-In Strategies After Tracheal Intubation. Trials, record NCT07894393. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07894393

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Haemodynamic Effects of Four Sevoflurane Wash-In Strategies After Tracheal Intubation
NCT number
NCT07894393
Status
Completed
Phases
Not applicable
Enrollment
102 participants, actual
Lead sponsor
Ataturk University
Conditions
Anesthesia, General, Hypotension
Interventions
End-tidal-controlled sevoflurane wash-in, Low-flow high-concentration wash-in (0.5 L/min, 8% sevoflurane), Low-flow wash-in (1 L/min, 4% sevoflurane), Moderate-flow wash-in (2 L/min, 4% sevoflurane)
First posted
2026-10-26
Last updated
2026-10-26

Source ClinicalTrials.gov

Registered outcomes17

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryCardiac index10 minutes after endotracheal intubationCardiac index (L/min/m2) measured with the pressure recording analytical method (PRAM; MostCare Up) via a radial arterial line, compared between the four wash-in groups.
SecondarySystolic arterial pressureBefore induction (T0), 30 seconds after intubation (T1), when 0.8 MAC is reached (T2) and 10 minutes after intubation (T3)
Systolic arterial pressure (mmHg) measured with the pressure recording analytical method (PRAM; MostCare Up) via a radial arterial line. At each time point, the highest value among five consecutive beats was recorded.
SecondaryDiastolic arterial pressureBefore induction (T0), 30 seconds after intubation (T1), when 0.8 MAC is reached (T2) and 10 minutes after intubation (T3)
Diastolic arterial pressure (mmHg) measured with the pressure recording analytical method (PRAM; MostCare Up) via a radial arterial line. At each time point, the highest value among five consecutive beats was recorded.
SecondaryMean arterial pressureBefore induction (T0), 30 seconds after intubation (T1), when 0.8 MAC is reached (T2) and 10 minutes after intubation (T3)
Mean arterial pressure (mmHg) measured with the pressure recording analytical method (PRAM; MostCare Up) via a radial arterial line. At each time point, the highest value among five consecutive beats was recorded.
SecondaryHeart rateBefore induction (T0), 30 seconds after intubation (T1), when 0.8 MAC is reached (T2) and 10 minutes after intubation (T3)
Heart rate (beats/min) measured with the pressure recording analytical method (PRAM; MostCare Up) via a radial arterial line. At each time point, the highest value among five consecutive beats was recorded.
SecondaryCardiac index at other time pointsBefore induction (T0), 30 seconds after intubation (T1) and when 0.8 MAC is reached (T2)
Cardiac index (L/min/m2) measured with the pressure recording analytical method (PRAM; MostCare Up) via a radial arterial line. At each time point, the highest value among five consecutive beats was recorded.
SecondaryStroke volume indexBefore induction (T0), 30 seconds after intubation (T1), when 0.8 MAC is reached (T2) and 10 minutes after intubation (T3)
Stroke volume index (mL/m2) measured with the pressure recording analytical method (PRAM; MostCare Up) via a radial arterial line. At each time point, the highest value among five consecutive beats was recorded.
SecondaryPulse pressure variation30 seconds after intubation (T1), when 0.8 MAC is reached (T2) and 10 minutes after intubation (T3)
Pulse pressure variation (%) measured with the pressure recording analytical method (PRAM; MostCare Up) via a radial arterial line. At each time point, the highest value among five consecutive beats was recorded. Not assessed at T0 because patients were breathing spontaneously.
SecondaryCardiac cycle efficiencyBefore induction (T0), 30 seconds after intubation (T1), when 0.8 MAC is reached (T2) and 10 minutes after intubation (T3)
Cardiac cycle efficiency (unitless index, range -1 to +1) measured with the pressure recording analytical method (PRAM; MostCare Up) via a radial arterial line. At each time point, the highest value among five consecutive beats was recorded.
SecondaryMaximum rate of arterial pressure rise (dP/dt)Before induction (T0), 30 seconds after intubation (T1), when 0.8 MAC is reached (T2) and 10 minutes after intubation (T3)
Maximum rate of rise of the radial arterial pressure, dP/dt (mmHg/ms) measured with the pressure recording analytical method (PRAM; MostCare Up) via a radial arterial line. At each time point, the highest value among five consecutive beats was recorded.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07894393

GET https://conductscience.org/api/trials/v1/NCT07894393/registered